{"id":"W4417014291","doi":"10.1182/blood-2025-3903","title":"Real-world (RW) use of fixed-duration (FD) ibrutinib+venetoclax (Ibr+Ven) in patients (pts) with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Pooled analysis of REALITY-worldwide (WW) and REALITY-2 prospective cohort studies","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Clinical trial; Clinical endpoint; Prospective cohort study; Adverse effect; Cohort study; Cohort; Discontinuation","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009061055,0.0008631253,0.001349624,0.00116338,0.0001607279,0.00120354,0.0006596784,0.000683097,0.001047129],"category_scores_gemma":[0.01090152,0.0004725321,0.006218365,0.001860831,0.0002900723,0.0007517289,0.001028253,0.0004464141,0.0001319891],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002711861,"about_ca_system_score_gemma":0.0002712676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00129191,"about_ca_topic_score_gemma":0.001877479,"domain_scores_codex":[0.9916208,0.004908442,0.001318373,0.001366449,0.0005715336,0.0002143543],"domain_scores_gemma":[0.9872854,0.004657845,0.005740415,0.001679692,0.0004493836,0.0001872638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02636607,0.0001452689,0.8009117,0.002965261,0.1466698,0.0001474732,0.0001515824,0.002117974,0.0008900625,0.0001409867,0.0007885555,0.01870524],"study_design_scores_gemma":[0.00252652,0.005510678,0.8715166,0.0006392111,0.1116898,0.0006435779,0.0003469514,0.002413282,0.0007645425,0.000270259,0.003587603,0.00009092913],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9628073,0.02620228,0.002240068,0.0001132124,0.00007308992,0.0001762384,0.007470965,0.00003921777,0.0008776308],"genre_scores_gemma":[0.9934741,0.001715561,0.000634212,0.00008248945,0.00004000355,0.0001109133,0.003804817,0.000009282506,0.0001286649],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009061055,"threshold_uncertainty_score":0.04791999,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02364489091999106,"score_gpt":0.3028390251495863,"score_spread":0.2791941342295953,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}